Unow™ CK-MB Fluorescence Immunoassay

Point-of-care rapid immunoassay for cardiac biomarker detection. Supports rapid assessment of cardiac events and myocardial injury in clinical settings.

Fluorescence immunoassay kit for rapid dual cardiac biomarker detection. Enables quantitative measurement of cardiac markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings. Compatible with automated analyzer platforms for efficient high-throughput testing.

A cardiac biomarker detection reagent series using microfluidic fluorescence immunoassay method to detect cardiac markers in human plasma or whole blood. The kit features high sensitivity of 5pg/mL, delivers results in 10 minutes, requires no centrifugation with built-in card filtration, supports room temperature storage, offers single-use disposable format, and utilizes dry microfluidic test cards with zero maintenance and no liquid waste.

Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.

Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.

Point-of-care rapid immunoassay for infectious disease detection. Enables fast identification of pathogens and infectious agents in clinical environments.

Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.

A microfluidic-based fluorescence immunoassay kit designed for point-of-care testing (POCT) applications. The kit leverages microfluidic chip technology for biological detection and analysis. It is part of Novos Biotech's product line for molecular diagnostics and has been selected for innovative medical device demonstration projects.

Rapid immunoassay kits designed for point-of-care testing in clinical settings. Provide quick turnaround results for various medical conditions with high accuracy.

B-Type Natriuretic Peptide (BNP) detection kit using fluorescence immunoassay technology for cardiac biomarker measurement. Enables rapid assessment of heart failure and acute dyspnea in clinical and laboratory settings. Supports diagnostic decision-making through quantitative BNP level analysis with high sensitivity and specificity.

Rapid immunoassay for detection of creatine kinase-MB in blood samples. Used for cardiac marker assessment in acute myocardial infarction diagnosis.

High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.